Cellosaurus CS-1/ER (CVCL_F1B2)
| Cell line name | CS-1/ER |
|---|---|
| Synonyms | CS-1/ET |
| Accession | CVCL_F1B2 |
| Resource Identification Initiative | To cite this cell line use: CS-1/ER (RRID:CVCL_F1B2) |
| Comments | Population: Caucasian. Characteristics: Exhibits cross resistance to cisplatin and methotrexate but not to doxorubicin (PubMed=19742314). Selected for resistance to: ChEBI; CHEBI_84050; Trabectedin (Ecteinascidin-743; ET-743). Omics: Transcriptomics; Microarray. Derived from site: Metastatic; Bone, humerus; UBERON=UBERON_0000976. |
| Disease | Chondrosarcoma (NCIt: C2946) Chondrosarcoma (ORDO: Orphanet_55880) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_T023 (CS-1 [Human chondrosarcoma]) |
| Sex of cell | Male |
| Age at sampling | 62Y |
| Category | Cancer cell line |
| Publications | PubMed=19742314; DOI=10.1371/journal.pone.0006967; PMCID=PMC2734182 |
| Cross-references | |
| Gene expression databases | GEO; GSM419913 |
| Entry history | |
| Entry creation | 27-Nov-2025 |
| Last entry update | 27-Nov-2025 |
| Version number | 1 |